Abstract
BACKGROUND: NHS services are under considerable strain, leading to delays in treatment that can cause increased harm to patients. Urgent and emergency care (UEC) centres are at the forefront of the NHS and as such are susceptible to these system pressures. Virtual wards (VWs) have been identified as a potential tool to help ease system pressures. A VW enables patients who would otherwise be in hospital to receive acute care and treatment in their usual place of residence or other community settings. VWs can facilitate an early discharge from a hospital setting (step-down care) or provide an alternative to hospital admission (step-up care). There is some evidence supporting the safety of VWs, but further evaluation is needed in the consideration of clinical efficacy and cost-effectiveness. This research evaluates why evidence generation in the field of VWs is challenging and discusses important factors for future evaluation, with a focus on the key pathways outlined by the NHS.
METHODS: A pragmatic literature review of multiple areas of VWs was undertaken to understand the fast-moving evidence within VWs. The pragmatic literature review was focused on safety, clinical effectiveness ,and cost-effectiveness outcomes. Gap analysis was then undertaken based on the evidence identified, to understand where future evidence generation should be prioritised. This included identifying the issues with generating evidence for VWs. The authors had previously led an early value assessment (EVA) for NICE as part of their role as an external assessment group, which involved patient and clinical engagement. The specific EVA was focussed on VW for acute respiratory infection. The authors used this experience to help inform the pragmatic searches and key areas for gap analysis.
RESULTS: The evidence base for VWs suggests that they are potentially safe and effective, although, the evidence is limited. The evidence supporting the clinical effectiveness of VWs varies between the patient cohort analysed and whether the ward provides step-up, step-down or mixed model care. Most evidence identified was non-comparative, or underpowered to capture some of the relevant outcomes. Case studies were reported for VWs implementation in the NHS in England. However, these studies lacked peer review, involved small sample sizes and lacked transparency surrounding the costing of VWs. Key issues were identified with the evaluation of VW, including the consideration of varying components which make up a tech-enabled VW, a lack of comparison to manual forms of a VW, accounting for different populations and subgroups associated with the use of VWs, and how a VW may distort the population when compared with standard care. Key areas for future evidence generation included prospective cohort studies to better understand clinical and resource use outcomes, identifying the impact of differences in VW features, as well as studies which can identify the true resource use associated with implementing and running a VW.
IMPLICATIONS & LIMITATIONS: Technology-enabled VWs are complex care systems. There is some evidence that they may provide resource benefits to the NHS. However, unless they are appropriately evaluated, we may not understand the true clinical efficacy, safety risks and costs associated with VW implementation. This is especially pertinent given the rapid expansion of VW facilities across the NHS. Future evaluation will be key to determine whether VWs are an effective alternative to hospital care, the features that may drive this effectiveness, and how these features could be harnessed to optimise effectiveness. Limitations of this research include the pragmatic nature of the review, as well as the generalisability of some of the identified evidence for VWs.